Canada· CA-DIN-00260428
DEPO-MEDROL WITH LIDOCAINE
A methylprednisolon, kombinationen product containing methylprednisolone acetate + lidocaine hydrochloride, registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 6 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Methylprednisolon, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC H02BX01 (methylprednisolon, kombinationen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 4 of them publish a price we can compare per daily dose
Methylprednisolon, kombinationen · ATC H02BX01
6 / 19 countries
- Canada
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- METHYLPREDNISOLONE ACETATE + LIDOCAINE HYDROCHLORIDE
- Manufacturer
- PFIZER CANADA ULC
- Country
- Canada (CA)
- ATC code
- H02BX01
- ATC class
- Methylprednisolon, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylprednisolon, kombinationen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDepo-Medrone with Lidocaine suspension for injection 1ml vialsDE Pharmaceuticals
- SwitzerlandDepo Medrol Lidocain
- SwedenDepo-Medrol cum lidocain 40 mg/ml+10 mg/ml Injektionsvätska, suspensionPfizer AB
- PolandDepo-Medrol z LidokainąPfizer Europe MA EEIG
- IrelandDepo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 2ml vialPfizer Healthcare Ireland Unlimited Company
- FinlandDepo-Medrol Cum LidocainPfizer Oy
- NetherlandsDepo Medrol + Lidocaïne, suspensie voor injectiePfizer B.V.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Depo-Medrol + Lidocain, Depo-Medrol + Lidocaïne
- Finland · Depo-Medrol Cum Lidocain
- United Kingdom (Northern Ireland) · Depo-Medrone With Lidocaine
- Ireland · Depo-Medrone With Lidocaine
- Italy · Lidodepomedrol
- Luxembourg · Depo-Medrol + Lidocain, Depo-Medrol + Lidocaïne
- Netherlands · Depo-Medrol + Lidocaïne
- Poland · Depo-Medrol Z Lidokainą
- Portugal · Depo-Medrol Com Lidocaína
- Sweden · Depo-Medrol Cum Lidocain
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e18d2aaa-e5cf-4af2-aa4d-1d7a344c9785 GET /v1/drugs/e18d2aaa-e5cf-4af2-aa4d-1d7a344c9785?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00260428",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"INTRASYNOVIAL",
"INTRABURSAL",
"PERIARTICULAR",
"INTRA-ARTICULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "H02BX01",
"schedule": [
"Prescription"
],
"drug_code": "1619",
"strengths": [
"40 MG",
"10 MG"
],
"ahfs_class": null,
"substances": [
"METHYLPREDNISOLONE ACETATE",
"LIDOCAINE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about methylprednisolon, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.